Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients.
Activities of Daily Living
Aged
Disability Evaluation
Europe
Exercise Test
Exercise Tolerance
Female
Health Status
Humans
Lung
/ physiopathology
Male
Middle Aged
Minimal Clinically Important Difference
Predictive Value of Tests
Prospective Studies
Pulmonary Disease, Chronic Obstructive
/ diagnosis
Quebec
Recovery of Function
Severity of Illness Index
Surveys and Questionnaires
Time Factors
Treatment Outcome
Walk Test
COPD
MCID
chair tests
outcomes assessment
pulmonary rehabilitation
tools
Journal
International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481
Informations de publication
Date de publication:
Historique:
entrez:
19
2
2019
pubmed:
19
2
2019
medline:
30
7
2019
Statut:
epublish
Résumé
The 3-minute chair rise test (3-minute CRT) and the Disability Related to COPD Tool (DIRECT) are two reproducible and valid short tests that can assess the benefit of pulmonary rehabilitation (PR) in terms of functional capacity and dyspnea in everyday activities. We determined the minimal clinically important difference (MCID) of the DIRECT questionnaire and 3-minute CRT using distribution methods and anchor encroaches with a panel of eight standard tests in a cohort of 116 COPD patients who completed a PR program in real-life settings. The estimated MCID for the 3-minute CRT and DIRECT scores was five repetitions and two units, respectively, using separate and combined independent anchors. The all-patient (body mass index-obstruction-dyspnea-exercise [BODE] scores 0-7), BODE 0-2 (n=42), and BODE 3-4 (n=50) groups showed improvements greater than the MCID in most tests and questionnaires used. In contrast, the BODE 5-7 group (n=24) showed improvements greater than MCID in only the 3-minute CRT, 6-minute walk test, endurance exercise test, and DIRECT questionnaire. This study demonstrates that the short and simple DIRECT questionnaire and 3-minute CRT are responsive to capture the beneficial effects of a PR program in COPD patients, including those with severe disease. NCT03286660.
Sections du résumé
BACKGROUND
BACKGROUND
The 3-minute chair rise test (3-minute CRT) and the Disability Related to COPD Tool (DIRECT) are two reproducible and valid short tests that can assess the benefit of pulmonary rehabilitation (PR) in terms of functional capacity and dyspnea in everyday activities.
METHODS
METHODS
We determined the minimal clinically important difference (MCID) of the DIRECT questionnaire and 3-minute CRT using distribution methods and anchor encroaches with a panel of eight standard tests in a cohort of 116 COPD patients who completed a PR program in real-life settings.
RESULTS
RESULTS
The estimated MCID for the 3-minute CRT and DIRECT scores was five repetitions and two units, respectively, using separate and combined independent anchors. The all-patient (body mass index-obstruction-dyspnea-exercise [BODE] scores 0-7), BODE 0-2 (n=42), and BODE 3-4 (n=50) groups showed improvements greater than the MCID in most tests and questionnaires used. In contrast, the BODE 5-7 group (n=24) showed improvements greater than MCID in only the 3-minute CRT, 6-minute walk test, endurance exercise test, and DIRECT questionnaire.
DISCUSSION AND CONCLUSION
CONCLUSIONS
This study demonstrates that the short and simple DIRECT questionnaire and 3-minute CRT are responsive to capture the beneficial effects of a PR program in COPD patients, including those with severe disease.
TRIAL REGISTRATION NUMBER
BACKGROUND
NCT03286660.
Identifiants
pubmed: 30774324
doi: 10.2147/COPD.S187567
pii: copd-14-261
pmc: PMC6349077
doi:
Banques de données
ClinicalTrials.gov
['NCT03286660']
Types de publication
Comparative Study
Journal Article
Multicenter Study
Observational Study
Langues
eng
Pagination
261-269Déclaration de conflit d'intérêts
Disclosure Financial support for this study was provided by an unrestricted grant from Boehringer Ingelheim, France. BA reports grants and other from Boehringer Ingelheim, France, during the conduct of the study. The authors report no other conflicts of interest in this work.
Références
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Lancet Respir Med. 2014 Mar;2(3):195-203
pubmed: 24621681
Eur Respir J. 2015 Dec;46(6):1625-35
pubmed: 26453626
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Prim Care Respir J. 2011 Sep;20(3):269-75
pubmed: 21523316
Chron Respir Dis. 2017 Nov;14(4):352-359
pubmed: 29081264
Eur Respir J. 2017 Mar 2;49(3):
pubmed: 28254766
Int J Chron Obstruct Pulmon Dis. 2014 Sep 23;9:1009-19
pubmed: 25285001
Pulm Med. 2013;2013:410748
pubmed: 23431439
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Eur Respir J. 2016 Feb;47(2):429-60
pubmed: 26797036
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373-86
pubmed: 26623686
J Clin Epidemiol. 2008 Feb;61(2):102-9
pubmed: 18177782
Thorax. 2013 Nov;68(11):1015-20
pubmed: 23783372
Eur Respir J. 2017 Mar 2;49(3):
pubmed: 28254769
Int J Chron Obstruct Pulmon Dis. 2016 Oct 19;11:2609-2616
pubmed: 27799759
J Am Med Dir Assoc. 2017 Jan;18(1):53-58
pubmed: 27624705
Int J Chron Obstruct Pulmon Dis. 2011;6:387-98
pubmed: 21760726
Eur Respir J. 2014 May;43(5):1326-37
pubmed: 24337043
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
N Engl J Med. 2004 Mar 4;350(10):1005-12
pubmed: 14999112
Eur Respir J. 1998 Aug;12(2):363-9
pubmed: 9727786
Am Rev Respir Dis. 1992 Jun;145(6):1321-7
pubmed: 1595997
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Health Qual Life Outcomes. 2008 Jul 02;6:46
pubmed: 18597689
Multidiscip Respir Med. 2010 Jun 30;5(3):202-10
pubmed: 22958431
Respirology. 2013 Aug;18(6):974-7
pubmed: 23521698
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809